JLJasmijn D. G. Linssen

Jasmijn D. G. Linssen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jasmijn D. G. Linssen has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Dirkje Willemien Sommeijer

    Cancer Center Amsterdam, Amsterdam, the Netherlands; Department of Internal Medicine, Flevo hospital, Almere, the Netherlands

    1 shared publication
  • Evelien Dekker

    Cancer Center Amsterdam, Laboratory for Experimental Oncology and Radiobiology Center for Experimental and Molecular Medicine Amsterdam The Netherlands

    1 shared publication
  • Felice N. van Erning

    Department of Surgery, Catharina Cancer Institute, Eindhoven, Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, Netherlands

    1 shared publication
  • Ignace H. J. T. de Hingh

    Department of Surgery Catharina Hospital Eindhoven the Netherlands

    1 shared publication
  • Louis Vermeulen

    Cancer Center Amsterdam, Laboratory for Experimental Oncology and Radiobiology Center for Experimental and Molecular Medicine Amsterdam The Netherlands

    1 shared publication
  • Louis Vermeulen

    Laboratory of Experimental Oncology and Radiobiology, Cancer Center Amsterdam, Amsterdam UMC and University of Amsterdam, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands

    1 shared publication

Latest Publications

  • Open Access

    Predisposing conditions in patients with small intestinal adenocarcinomas in the Netherlands: A 20‐year nationwide cohort study

    by Jasmijn D. G. Linssen, Pascale J. M. Schafrat, Tim R. de Back, Felice N. van Erning, Monique E. van Leerdam, Evelien Dekker, Louis Vermeulen, Ignace H. J. T. de Hingh, Dirkje W. Sommeijer

    Small intestinal adenocarcinomas (SIAs) are associated with predisposing conditions, including inflammatory bowel disease (IBD) and celiac disease, but also genetic syndromes such as Lynch syndrome (LS) and familial adenomatous polyposis (FAP). This nationwide cohort study investigated the incidence of genetic and non‐genetic predisposing conditions in SIA and their influence on tumor characteristics and clinical features. Data were obtained from the Netherlands Cancer Registry. The incidence, characteristics, and clinical features per predisposing condition were analyzed in 2697 SIA patients diagnosed from 1999 through 2019. Of all SIA patients, 5.6% were known to have a genetic predisposing syndrome, of whom 4.0% had LS and 1.6% had a polyposis syndrome. In addition, 6.8% of SIA patients had a non‐genetic predisposing condition: 3.9% IBD and 2.9% celiac disease. SIAs of patients with such predisposing syndromes or conditions were diagnosed at a younger age and earlier stage and affected the duodenum less often as compared to sporadic SIA patients. Both genetic and non‐genetic predisposing conditions were associated with significantly better overall survival (OS) compared to sporadic SIA: sporadic SIA (median OS: 13.0 months, 95% CI: 11.8–14.2), LS (213.1 months, 99.3–NA), polyposis syndromes (61.3 months, 19.7–NA), IBD (29.5 months, 20.3–69.8), and celiac disease (50.4 months, 24.6–124.7). This nationwide cohort study shows significant differences between SIA with and without predisposing conditions and highlights the need for research on underlying molecular mechanisms to improve outcomes of SIA patients.


  • Open Access

    Pleiotropic role of NOTUM in colorectal cancer

    by Milou S van Driel, Jasmijn D G Linssen, Sanne M van Neerven, Louis Vermeulen